Biohacker Network
PeptidesEvidence: Standards-based

How to Reconstitute Peptides: The Arithmetic, the Technique & the Limits

Medically reviewed by
Dr. Sarah Lindqvist, MD
Published
June 20, 2025
Updated
June 20, 2025
Last medical review
June 20, 2025
Reviewer scope
Metabolic health
Insulin syringe drawing reconstituted peptide solution from a vial after mixing with bacteriostatic water

Reconstituting a peptide means dissolving the lyophilized powder in a diluent — usually bacteriostatic water — so a prescribed dose can be measured. The math is fixed: concentration equals vial amount divided by diluent volume, and draw volume equals the prescribed dose divided by that concentration. The technique standards come from USP <797>; the dose must come from a licensed clinician.

The arithmetic, worked once

A 5 mg vial reconstituted with 2 mL of diluent yields 2.5 mg/mL (2,500 mcg/mL). For a clinician-prescribed 250 mcg dose: 250 ÷ 2,500 = 0.1 mL, which is 10 units on a U-100 insulin syringe. That vial holds 20 such doses. Our reconstitution calculator runs exactly this math and nothing else.

Gloved hands holding a sterile syringe against a dark background, demonstrating aseptic peptide reconstitution technique per USP 797

Technique points that actually matter

  • Inject diluent slowly down the vial wall — peptide bonds are mechanically fragile; do not shake
  • Swab stoppers with alcohol and let them dry
  • Use a sterile syringe per puncture and never share vials
  • Refrigerate after reconstitution; stability windows are compound- and pharmacy-specific
  • Label the vial with date and concentration immediately

Before you mix anything, get the diluent right: our bacteriostatic water guide covers the 0.9% benzyl alcohol question, the bac-water mixing examples show how volume choices change syringe readability, and the same-syringe compatibility review explains why combining compounds is a pharmacist’s question. When you have a prescription in hand, the reconstitution calculator runs the math.

What reconstitution cannot fix

No mixing ratio makes an unapproved compound safe or a gray-market vial pure. Most research peptides are not FDA-approved, and several sit on the FDA list of compounding substances with significant safety risks. Sterile arithmetic on an unverified product is still an unverified product.

Why we require a clinician-supplied dose

This page reports what published studies and regulatory documents describe. It never recommends a dose — dosing is a clinical decision for a licensed prescriber who knows your history.

Frequently asked questions

How much bacteriostatic water do I add to a 5 mg peptide vial?
There is no single correct volume — the amount you add sets the concentration, not the total peptide. Adding 2 mL to a 5 mg vial yields 2.5 mg/mL; adding 3 mL yields about 1.67 mg/mL. Choose a volume that makes your clinician-prescribed dose land on an easily read syringe graduation.
Can I use sterile water instead of bacteriostatic water?
Plain sterile water contains no preservative and is intended for single immediate use. For multi-dose vials punctured repeatedly over days or weeks, bacteriostatic water (0.9% benzyl alcohol) is the standard because it suppresses bacterial growth between punctures. Your pharmacy label governs.
How long does a reconstituted peptide last in the fridge?
Stability windows are compound- and pharmacy-specific. Refrigerate immediately, label the vial with the date and concentration, and follow the beyond-use date on your pharmacy label. Cloudiness or particles disqualify a vial regardless of date.
Should I shake the vial to mix a peptide?
No. Peptide bonds are mechanically fragile — inject the diluent slowly down the inside wall of the vial and swirl gently until dissolved. Shaking can degrade the peptide without any visible warning.

Questions to ask a licensed clinician

  • What diluent and storage window applies to my specific prescription?
  • Who verifies the purity of what I was dispensed?

References

  1. US Pharmacopeia (2023). General Chapter <797> Pharmaceutical Compounding — Sterile Preparations. USP-NF. SourceStandard
  2. US Food and Drug Administration (2023). Certain bulk drug substances for use in compounding that may present significant safety risks. FDA Human Drug Compounding. SourceAgency notice

Something incorrect in this guide? Report a correction. Material corrections are noted on the page with the date and nature of the change.